Scholars@Duke
Cara L. McDermott

Cara L. McDermott

Assistant Professor in Medicine
Medicine, Geriatrics and Palliative Care

Scholarly Works - Conferences

C35-15 It’s Better to Have Some Medication Than No Medication: Barriers and Facilitators to Deprescribing in Older Adults With Chronic Obstructive Pulmonary Disease

Conference American Journal of Respiratory and Critical Care Medicine · May 1, 2026 AbstractRationalePeople living with chronic obstructive pulmonary disease (COPD) have a high medication burden, which in turn i ... Full text Cite

Evaluating Generative AI for Deprescribing: Accuracy, Safety, and Clinical Utility

Conference Innovation in Aging · December 1, 2025 AbstractLimited geriatrics and pharmacy resources in VA Medical Centers (VAMCs) necessitate innovative strategies to enhance deprescribing efforts. Generative AI platforms, such as OpenAI, have the potent ... Full text Cite

"I Need Electricity to Live": An Analysis of GoFundMe Campaigns for Obstructive Lung Disease

Conference American Journal of Respiratory and Critical Care Medicine · May 1, 2025 AbstractRATIONALE: Raising money through online crowdfunding platforms is a popular way to pay for medical expenses. Analyzing medical crowdfunding campaigns can illuminate the financial struggles that pa ... Full text Cite

Medical crowdfunding for persons with dementia and their families

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · April 2025 Link to item Cite

Medical crowdfunding for persons with dementia and their families

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · April 2025 Link to item Cite

LIVING WITH MULTIMORBIDITY AND FINANCIAL TOXICITY: A PATIENT- AND CLINICIAN-INFORMED FRAMEWORK

Conference Innovation in Aging · December 31, 2024 AbstractMost older adults in the US have multimorbidity (2+ serious illnesses). Living with multimorbidity impacts patient quality of life, specifically managing the symptoms of multiple diseases and accompa ... Full text Cite

Factors Associated with Hospital Admission in the Last Month of Life

Conference JOURNAL OF PAIN AND SYMPTOM MANAGEMENT · May 2024 Link to item Cite

Factors Associated with Hospital Admission in the Last Month of Life

Conference JOURNAL OF PAIN AND SYMPTOM MANAGEMENT · May 2024 Link to item Cite

Patient-Informed Framework to Address Financial Toxicity in Multimorbidity

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · April 2024 Link to item Cite

Polypharmacy and medication costs at end of life among commercially insured adults age 65 and older with cancer.

Conference Journal of Clinical Oncology · December 1, 2018 65 Background: Polypharmacy, or the concurrent use of multiple medications, may expose patients to drug-drug interactions and excessive costs. There are limited data on polypharmacy for commercially insured older adults, primaril ... Full text Cite

How do clinics perform across multiple end of life metrics?

Conference Journal of Clinical Oncology · November 1, 2017 86 Background: National bodies have proposed a number of metrics to measure quality of care at the end of life (EOL). MACRA legislation allows clinics to select the metrics they report to CMS. The self-selection of reported metri ... Full text Cite

Polypharmacy and out-of-pocket medication costs in the last month of life among commercially insured patients with advanced cancer: Insights from linking a regional cancer registry and insurance claims.

Conference Journal of Clinical Oncology · November 1, 2017 79 Background: Polypharmacy, defined as the concurrent use of multiple medications, may expose patients to drug-drug interactions and excessive medication costs. Patients with advanced cancer may benefit from medication discontin ... Full text Cite

Development of cancer care episodes to measure costs for breast, colorectal, and non-small cell lung cancer.

Conference Journal of Clinical Oncology · March 10, 2017 29 Background: Cancer care costs are rising, creating concerns about affordability. As a result, delivery systems are creating alternative payment structures to lower costs while maintaining or improving quality. As cancer care d ... Full text Cite

Health care utilization and costs at end of life among patients with leukemia or lymphoma in a regional cancer registry-insurance claims linked database.

Conference Journal of Clinical Oncology · October 9, 2016 184 Background: End-of-life (EOL) care for persons with hematologic malignancies is variable and often involves high-intensity services at death approaches, which may not reflect patient or family preferences. We characterized he ... Full text Cite